Small Cap Cannabis Stock Beats Wall Street Expectations By 513%

Trulieve Cannabis (TCNNF) is a multi-state cannabis firm that has made big waves in the marijuana market. 

What makes this company enticing is the fact that it’s a small, yet profitable cannabis operator.

In its most recent quarter, the company reported earnings before interest, taxes, depreciation, and amortization (EBITDA) of $90.8 million… Compared to Wall Street’s projected $14.8 million (a 513% surprise).

Meanwhile, the company’s revenue for the quarter was $193.8 million versus the estimated $189.2 million. Trulieve’s gross margin – or the revenue a firm retains after accounting for costs – came in at an impressive 70%.

Much of this can be attributed to TCNNF’s rapid expansion across the U.S.

In May, the firm completed its acquisition of West Virginian marijuana company Mountaineer Holding.

Through the deal, TCNNF obtained the company’s cultivation license and access to two dispensary permits. 

Trulieve recently announced it would acquire Harvest Health, Solevo Wellness, and Keystone Shops as well. 

This suggests that with increased legalization on the state level, the company is well-positioned to benefit from the herb’s growing popularity.

As the U.S. continues to look into possibly legalizing it on a federal level, TCNNF should benefit as well, as it has established its presence in several key markets.

Make THIS your next play…

$2 EV Stock No One's Talking About

This company is a sneaky EV play that no one’s talking about. They’re producing an odd variation on the traditional EV that has consumers raving.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

53-cent Biotech Stock with $2 Price Target

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only 53 cents.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works